Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Urethral cancer: Which Medications Are Safest? (44 Drugs Compared)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

44 medications are used for Urethral cancer, with 100 combined adverse event reports. The most reported drugs for Urethral cancer are PEMBROLIZUMAB and CISPLATIN.

100
Total Reports
44
Drugs Used

All Medications for Urethral cancer Ranked by Safety Reports

Drug Brand Reports Deaths (all) Hosp. (all) Death Rate
PEMBROLIZUMAB KEYTRUDA 21 15,543 35,472 18.6%
CISPLATIN CISplatin 18 8,387 17,469 17.7%
ATEZOLIZUMAB Tecentriq Hybreza 8 8,520 15,094 25.3%
ERDAFITINIB BALVERSA 8 315 226 28.5%
GEMCITABINE Gemcitabine 7 5,142 12,268 16.4%
NIVOLUMAB OPDIVO 6 23,086 36,530 26.3%
CAPECITABINE Capecitabine 5 8,892 17,529 14.0%
CARBOPLATIN Carboplatin 5 12,544 35,869 14.9%
GEMCITABINE\GEMCITABINE - 5 2,206 3,666 21.6%
PACLITAXEL PACLITAXEL PACLITAXEL 5 12,030 31,638 15.6%

View all 44 drugs →

Most Reported Drugs for Urethral cancer

#1 most reported
#2 most reported
#3 most reported